96 related articles for article (PubMed ID: 17668873)
1. Aging in rat causes hepatic hyperresposiveness to interleukin-1beta which is mediated by neutral sphingomyelinase-2.
Rutkute K; Karakashian AA; Giltiay NV; Dobierzewska A; Nikolova-Karakashian MN
Hepatology; 2007 Oct; 46(4):1166-76. PubMed ID: 17668873
[TBL] [Abstract][Full Text] [Related]
2. Expression of neutral sphingomyelinase-2 (NSMase-2) in primary rat hepatocytes modulates IL-beta-induced JNK activation.
Karakashian AA; Giltiay NV; Smith GM; Nikolova-Karakashian MN
FASEB J; 2004 Jun; 18(9):968-70. PubMed ID: 15059969
[TBL] [Abstract][Full Text] [Related]
3. Regulation of neutral sphingomyelinase-2 by GSH: a new insight to the role of oxidative stress in aging-associated inflammation.
Rutkute K; Asmis RH; Nikolova-Karakashian MN
J Lipid Res; 2007 Nov; 48(11):2443-52. PubMed ID: 17693623
[TBL] [Abstract][Full Text] [Related]
4. Protein phosphatase 2A and neutral sphingomyelinase 2 regulate IRAK-1 protein ubiquitination and degradation in response to interleukin-1beta.
Dobierzewska A; Giltiay NV; Sabapathi S; Karakashian AA; Nikolova-Karakashian MN
J Biol Chem; 2011 Sep; 286(37):32064-73. PubMed ID: 21708940
[TBL] [Abstract][Full Text] [Related]
5. Regulation of insulin-like growth factor binding protein-1 expression during aging.
Rutkute K; Nikolova-Karakashian MN
Biochem Biophys Res Commun; 2007 Sep; 361(2):263-9. PubMed ID: 17645865
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 1β regulation of FoxO1 protein content and localization: evidence for a novel ceramide-dependent mechanism.
Dobierzewska A; Shi L; Karakashian AA; Nikolova-Karakashian MN
J Biol Chem; 2012 Dec; 287(53):44749-60. PubMed ID: 23105097
[TBL] [Abstract][Full Text] [Related]
7. Direct regulation of IGF-binding protein 1 promoter by interleukin-1β via an insulin- and FoxO-1-independent mechanism.
Shi L; Banerjee D; Dobierzewska A; Sathishkumar S; Karakashian AA; Giltiay NV; Nikolova-Karakashian MN
Am J Physiol Endocrinol Metab; 2016 Apr; 310(8):E612-E623. PubMed ID: 26884383
[TBL] [Abstract][Full Text] [Related]
8. The kinase activities of interleukin-1 receptor associated kinase (IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cells.
Song KW; Talamas FX; Suttmann RT; Olson PS; Barnett JW; Lee SW; Thompson KD; Jin S; Hekmat-Nejad M; Cai TZ; Manning AM; Hill RJ; Wong BR
Mol Immunol; 2009 Apr; 46(7):1458-66. PubMed ID: 19181383
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the JNK pathway by TGF-beta activated kinase 1 in rheumatoid arthritis synoviocytes.
Hammaker DR; Boyle DL; Inoue T; Firestein GS
Arthritis Res Ther; 2007; 9(3):R57. PubMed ID: 17559674
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1β/Iinterleukin-1 receptor-associated kinase 1 inflammatory signaling contributes to persistent Gankyrin activation during hepatocarcinogenesis.
Su B; Luo T; Zhu J; Fu J; Zhao X; Chen L; Zhang H; Ren Y; Yu L; Yang X; Wu M; Feng G; Li S; Chen Y; Wang H
Hepatology; 2015 Feb; 61(2):585-97. PubMed ID: 25294684
[TBL] [Abstract][Full Text] [Related]
11. Amyloid beta peptide increases DP5 expression via activation of neutral sphingomyelinase and JNK in oligodendrocytes.
Chen S; Lee JM; Zeng C; Chen H; Hsu CY; Xu J
J Neurochem; 2006 May; 97(3):631-40. PubMed ID: 16524368
[TBL] [Abstract][Full Text] [Related]
12. Modulation of amyloid-beta-induced and age-associated changes in rat hippocampus by eicosapentaenoic acid.
Minogue AM; Lynch AM; Loane DJ; Herron CE; Lynch MA
J Neurochem; 2007 Nov; 103(3):914-26. PubMed ID: 17711425
[TBL] [Abstract][Full Text] [Related]
13. Activation of neutral sphingomyelinase by IL-1beta requires the type 1 interleukin 1 receptor.
Nalivaeva NN; Rybakina EG; Pivanovich IYu ; Kozinets IA; Shanin SN; Bartfai T
Cytokine; 2000 Mar; 12(3):229-32. PubMed ID: 10704249
[TBL] [Abstract][Full Text] [Related]
14. LDL induces Saos2 osteoblasts death via Akt pathways responsive to a neutral sphingomyelinase inhibitor.
Klein BY; Kerem Z; Rojansky N
J Cell Biochem; 2006 Jun; 98(3):661-71. PubMed ID: 16440306
[TBL] [Abstract][Full Text] [Related]
15. Role of neutral sphingomyelinases in aging and inflammation.
Nikolova-Karakashian M; Karakashian A; Rutkute K
Subcell Biochem; 2008; 49():469-86. PubMed ID: 18751923
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1-induced interleukin-6 synthesis is mediated by the neutral sphingomyelinase/Src kinase pathway in neurones.
Tsakiri N; Kimber I; Rothwell NJ; Pinteaux E
Br J Pharmacol; 2008 Feb; 153(4):775-83. PubMed ID: 18059318
[TBL] [Abstract][Full Text] [Related]
17. Ceramide- and ERK-dependent pathway for the activation of CCAAT/enhancer binding protein by interleukin-1beta in hepatocytes.
Giltiay NV; Karakashian AA; Alimov AP; Ligthle S; Nikolova-Karakashian MN
J Lipid Res; 2005 Nov; 46(11):2497-505. PubMed ID: 16106045
[TBL] [Abstract][Full Text] [Related]
18. Activation of c-Jun-N-terminal kinase is critical in mediating lipopolysaccharide-induced changes in the rat hippocampus.
Barry CE; Nolan Y; Clarke RM; Lynch A; Lynch MA
J Neurochem; 2005 Apr; 93(1):221-31. PubMed ID: 15773921
[TBL] [Abstract][Full Text] [Related]
19. Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1beta-mediated reduction and modification of murine hepatic nuclear retinoid X receptor alpha.
Kosters A; White DD; Sun H; Thevananther S; Karpen SJ
J Hepatol; 2009 Nov; 51(5):898-908. PubMed ID: 19767119
[TBL] [Abstract][Full Text] [Related]
20. IL-1R-associated kinase-1 mediates protein kinase Cδ-induced IL-1β production in monocytes.
Tiwari RL; Singh V; Singh A; Barthwal MK
J Immunol; 2011 Sep; 187(5):2632-45. PubMed ID: 21804018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
